An allelotype of papillary thyroid cancer

International Journal of Cancer

Volumn 69, Issue 6, 1996, Pages 442-444

  Califano, Joseph A ^a   Johns III, Michael M ^b   Westra, William H ^a   Lango, Miriam N ^c   Eisele, David ^a   Saji, Motoyasu ^a   Zeiger, Martha A ^a   Udelsman, Robert ^a   Koch, Wayne M ^a   Sidransky, David ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; CHROMOSOME DELETION; CLINICAL ARTICLE; HETEROZYGOSITY LOSS; HUMAN; PRIORITY JOURNAL; THYROID PAPILLARY CARCINOMA; TUMOR SUPPRESSOR GENE;

ALLELES; CARCINOMA, PAPILLARY; CHROMOSOME ABERRATIONS; DNA, NEOPLASM; HETEROZYGOTE; HUMANS; MICROSATELLITE REPEATS; POLYMERASE CHAIN REACTION; THYROID NEOPLASMS;

EID: 8044230702     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961220)69:6<442::AID-IJC3>3.0.CO;2-4     Document Type: Article

References (21)

1. BONGARZONE, I., PIEROTTI, M.A., MONZINI, N., MONDELLINI, P., MANENTI, G., DONGHI, R., PILOTTI, S., GRIECO, M., SANTORO, M. and Fusco, A., High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene, 4, 1457-1462 (1989).
2. CADY, B. and ROSSI, R., An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery, 104, 947-953 (1988).
3. FAGIN, J.A., Molecular genetics of human thyroid neoplasms. Ann. Rev. Med., 45, 45-52 (1994).
4. GOEPFERT, H. and CALLENDER, D.L., Differentiated thyroid cancer - papillary and follicular carcinomas. Amer. J. Otolaryngol., 15, 167-169 (1994).
5. ITO, T., SEYAMA, T., MIZUNO, T., TSUYAMA, N., HAYASHI, Y., HAYASHI, T., DOHI, K., NNAKAMURA, N. and AKIYAMA, M., Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland. Cancer Res., 52, 1369-1371 (1992).
6. KUBO, K., YOSHIMOTO, K., YOKOGOSHI, Y., TSUYUGUCHI, M. and SAITO, S., Loss of heterozygosity on chromosome 1p in thyroid adenoma and medullary carcinoma, but not in papillary carcinoma. Jpn. J. Cancer Res., 82, 1097-1103 (1991).
7. LEMOINE, N.R., MAYALL, E.S., WYLLIE, F.S., WILLIAMS, E.D., GOYNS, M. and STRINGER, B., High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene, 4, 159-164 (1989).
8. MATSUO, K., TANG, S. and FAGIN, J., Allelotype of human thyroid tumors: loss of chromosome 11q13 sequences in follicular neoplasms. Mol. Endocrinol., 5, 1873-1879 (1991).
9. MCCONAHEY, W.M., HAY, I.D., WOOLNER, L.B., VAN HEERDEN, J.A. and TAYLOR, W.F., Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clinic Proc., 61, 978-996 (1986).
10. MITRA, A.B., MURTY, V.V., LI, R.G., PRATAP, M., LUTHRA, U.K. and CHAGANTI, R.S., Allelotype analysis of cervical carcinoma. Cancer Res., 54, 1772-1774 (1994).
11. NAMBA, H., GUTMAN, R.A., MATSUO, K., ALVAREZ, A. and FAGIN, J.A., H-ras protooncogene mutations in human thyroid neoplasms. J. clin. Endocrinol. Metab., 71, 223-229 (1990).
12. ROBBINS, J., MERINO, M.J., BOICE, J.D., RON, E., AIN, K.B., ALEXANDER, H.R., NORTON, J.A. and REYNOLDS, J., Thyroid cancer: a lethal endocrine neoplasm. Ann. Int. Med., 115, 133-147 (1991).
13. ROQUE, L., CLODE, A.L., GOMES, P., ROSA-SANTOS, J., SOARES, J. and CASTEDO, S., Cytogenetic findings in 31 papillary thyroid carcinomas. Genes Chromosomes Cancer, 13, 157-162 (1995).
14. SOZZI, G., BONOARZONE, I., MIOZZO, M., CARIANI, C.T., MONDELLINI, P., CALDERONE, C., PILOTTI, S., PIEROTTI, M.A. and DELLA PORTA, G., Cytogenetic and molecular genetic characterization of papillary thyroid carcinomas. Genes Chromosomes Cancer, 5, 212-218 (1992).
15. SUAREZ, H.G., DU VILLARD, J.A., SEVERING, M., CAILLOU, B., SCHLUMBERGER, M., TUBIANA, M., PARMENTIER, C. and MONIER, R., Presence of mutations in all three ras genes in human thyroid tumors. Oncogene, 5, 565-570 (1990).
16. TAKAHASHI, S., SHAN, A.L., RITLAND, S.R., DELACEY, K.A., BOSTWICK, D.G., LIEBER, M.M., THIBODEAU, S.N. and JENKINS, R.B., Frequent loss of heterozygosity at q13.1 in primary prostate cancer is associated with tumor aggressiveness and progression. Cancer Res., 55, 4114-4119 (1995).
17. VAN DER RIET, P., KARP, D., FARMER, E., WEI, Q., GROSSMAN, L., TOKINO, K., RUPPERT, J.M. and SIDRANSKY, D., Progression of basal cell carcinoma through loss of chromosome 9q and inactivation of a single p53 allele. Cancer Res., 54, 25-27 (1994).
18. WIELAND, I. and BOHM, M., Frequent allelic deletion at a novel locus on chromosome 5 in human lung cancer. Cancer Res., 54, 1772-1774 (1994).
19. WRIGHT, P.A., LEMOINE, N.R., GORETZKI, P.E., WYLLIE, F.S., BOND, J., HUGHES, C., ROHER, H.D., WILLIAMS, E.D. and WYNFORD-THOMAS, D., Mutation of the p53 gene in a differentiated human thyroid carcinoma cell line, but not in primary tumors. Oncogene, 6, 1693-1697 (1991).
20. ZEKI, K., SPAMBALG, D., SHARIFI, N., GONSKY, N. and FAGIN, J.A., Mutations of the adenomatous polyposis coli gene in sporadic thyroid neoplasm. J. clin. Endocrinol. Metab., 79, 1317-1321 (1994).
21. ZENKLUSEN, J.C., THOMPSON, J.C., KLEIN-SZANTO, A.J. and CONTI, C.J., Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: evidence for a broad range tumor suppressor gene. Cancer Res., 55, 1347-1350 (1995).